関連する実験動画

Updated: Jan 7, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

3.0K

ミトコンドリアとシナプス経路を交差させ,ALSの病理性を改善したGM1

Federica Pilotto1,2, Tristan Dellazizzo Toth3,4, Silvano Bond3,4

  • 1Institut Neuromyogène, Pathophysiology and genetics of the neuron and muscle, Inserm U1315, CNRS, Université Claude Bernard Lyon I, Lyon, France.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 5, 2026
PubMed
まとめ

No abstract available in PubMed .

キーワード:
C9ORF72 についてERとミトコンドリアの接触GM1 についてSOD1‐G93Aについてアミオトロフィック横筋硬化症 (ALS)ミトコンドリア機能障害ナノリポソーマル製剤プロテオミクスシナプス機能障害

さらに関連する動画

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.0K
Axonal Transport of Organelles in Motor Neuron Cultures using Microfluidic Chambers System10:12

Axonal Transport of Organelles in Motor Neuron Cultures using Microfluidic Chambers System

Published on: May 5, 2020

10.6K

関連する概念動画

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744